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Editorial on the Research Topic
Cross-Domain Analysis for “All of Us” Precision Medicine
Precision medicine aims to combat complex human diseases by providing preventative, diagnostic,
and treatment tools for each patient rather than each cohort. Along with the development of
precision medicine (formerly called personalized medicine) (Aronson and Rehm, 2015), the recent
“All of Us” initiative seeks to gather data related to “lifestyle, environment, and biology” from a
wide range of people in order to better understand individual differences and improve precision
medicine (All of Us Research Program Investigators et al., 2019). “All of Us” precision medicine
is seeking easy, low-cost, non-invasive, and effective early clinical detection approaches, which
include novel biological technology (BT) and information technology (IT) in precision healthcare
research. Importantly, many types/domains of data from new technologies can be utilized, such as
voice/text recording, image scanning, behavioral monitoring, and feature phenotyping, in addition
to omics data from high-throughput technologies (Zeng, 2021). These consist of cross-domain
data, where the micro cross-domain can cover conventional omics data and the macro cross-
domain can bridge the omics with other data types. Therefore, the cross-domain analysis is a key
to understanding “All of Us” precision medicine.
In particular, the artificial intelligence (AI) model and method (e.g., deep learning) has achieved
great success in analyzing image data in many fields and is bringing new opportunities to clinical
research (Zeng et al., 2021). However, for cross-domain analysis in “All of Us” precision medicine,
several challenges still exist: the numbers of variables in different domains are unbalanced, and
the bias coming from the dominant domain should be tackled (Zhang et al., 2020); the number
of observations is small or not large enough in clinical or biological fields, thus small-sample
modeling is required (Lai et al., 2020); the samples in different domains may be not matched,
so that heterogeneous integration should be considered (Yang et al., 2020); and many data
organizations exist, so data without a vector or matrix form needs a reasonable and powerful
transformation/representation (Wang et al., 2021).
This Research Topic serves as an update of our previous topic (Zeng et al., 2019), “Machine
Learning Advanced Dynamic Omics Data Analysis for Precision Medicine,” with a focus on the
application of artificial intelligence with cross-domain data for further developing “All of Us”
precision medicine.
At present, we do not have a clear understanding of the molecular pathogenesis of patent ductus
arteriosus (PDA). Chen et al. screened the rare copy number variants of 39 PDA patients and
100 healthy children by whole exome sequencing. This study was narrowed down by network and
enrichment based analysis, and finally selected 7 candidate genes significantly expressed in human
embryonic heart, which include CHRNA4 as potential genetic cause of PDA.
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Yan et al. investigated the potential of serum miRNAs as
signatures for pancreatic cancer (PC). First, they analyzed the
expression differences of miRNAs between PC patients and
healthy controls by feature selection approaches, obtaining
a group of PC signatures. Next they compared miRNAs’
expressions between inoperable and operable PC patients,
identifying lots of operability miRNAs. These findings
revealed a non-invasive way on the diagnosis and therapy
of pancreatic cancer.
Xu et al. applied network-based bioinformatics analysis
for reanalyzing temporal gene expression data related to
Infantile hemangioma (IH), with the purpose of distinguishing
genes for proliferative and regressive IH lesions. This analysis
pipeline included Short Time-series Expression Miner, weighted
gene co-expression network analysis, and area under curve
ranking, which determined key hub genes which were verified
using qRTPCR.
Restoration of altered transcriptional regulations in disease
states should be an important action for the pathogen genes
associated with disease diagnosis and prognosis (Lu et al., 2020).
The quantitative relation between transcriptional regulation and
disease phenotypes can help detect such targeted genes for
transcriptional modification. Duan et al. proposed a model-
based quantitative relationship measurement between mRNA
(non-TF) genes and Transcription Factor (TF) genes. They
further applied this method to detect quantitatively altered
mRNA genes in lung cancer on the basis of one learning
dataset and several independent evaluation datasets, which
provided new candidates for lung cancer diagnosis, prognosis,
and treatment.
Complex diseases are determined by many heterogeneous
biological factors (Su et al., 2020), thus, omics integration analysis
should help capture new prognostic signatures and models for
disease prognosis. Ren et al. explored the key biomarkers of
early-stage Lung adenocarcinoma and built a prognostic model
on the combination of gene transcription and methylation. In
the re-analysis of public RNA-seq and methylation microarray
data, with a series of statistical, network-based and machine
learning approaches, a prognostic index based on 17 methylation
driver genes, and 4 CD8T cell-related genes was established for
predicting the survival risk of lung cancer patients in early-stage.
Finally, we sincerely thank the reviewers; their great efforts
ensure the high quality of all articles in this topic. This Research
Topic should bring more attention to the important topics of
“All of Us” precision medicine based on machine learning and
cross-domain data.
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